Cellogin Research Institute is performing search of new drug candidates, isolation and identification of cell lines and test of the pharmacological effects with deer antler-derived cells. Furthermore, Cellogin Research Institute is searching the development of biopharmaceuticals, the acquisition of individual new raw materials for health functional foods and the availability of new raw materials for bio-agriculture. Based on these effort, Cellogin Research Institute has the capability of researching cell technology that can be applied to the entire biotechnology industry, including large-scale production of culture media.
Cellogin Research Institute is committed to technology research and product development so as to be a future growth engine and the foundation of the next-generation bio-industry through the Cellogin’s core technology (Platform Technology).

Cellogin Research Institute takes a role to research and develop the core technology of our business. Cellogin exclusively possesses deer antler-derived cells and culture technique by patent which is based on the results of research and development. Cellogin Research Institute is conducting research and development to enable commercialization by applying the core technology of deer antler-derived cells to various fields through the liquid raw material, deer antler cell culture fluid.